Drreddys Laboratories | RDY - Stock


Drreddys Laboratories reported INR79.01B in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
ANI Pharmaceuticals USD 146.48M 8.16M Sep/2025
Aurora Cannabis CAD 221.96M 6.3M Sep/2025
Bayer EUR 12.33B 221M Sep/2025
Canopy Growth CAD 102.37M 8.55M Sep/2025
Cipla INR 61.6B 5.18B Sep/2025
Corcept Therapeutics USD 12.35M 73K Sep/2025
Drreddys Laboratories INR 79.01B 3.41B Dec/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Hikma Pharmaceutical USD 1.08B 96M Jun/2025
Lonza CHF 1.68B 163M Dec/2025
Novartis USD 6.42B 114M Sep/2025
Pacira USD 157.68M 9.52M Sep/2025
Prestige Brands USD 163.59M 4.6M Dec/2025
Richter Gedeon HUF 205.75B 9.76B Jun/2024
Sun Pharmaceuticals INR 102.43B 3.08B Mar/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025